ATE448203T1 - 1-benzyl-4-ä(5,6-dimethoxy-1-indanon)-2- ylümethylpiperidinoxalat und dessen polymorphen - Google Patents

1-benzyl-4-ä(5,6-dimethoxy-1-indanon)-2- ylümethylpiperidinoxalat und dessen polymorphen

Info

Publication number
ATE448203T1
ATE448203T1 AT04806734T AT04806734T ATE448203T1 AT E448203 T1 ATE448203 T1 AT E448203T1 AT 04806734 T AT04806734 T AT 04806734T AT 04806734 T AT04806734 T AT 04806734T AT E448203 T1 ATE448203 T1 AT E448203T1
Authority
AT
Austria
Prior art keywords
indanone
dimethoxy
benzyl
ylümethylpiperidinoxalate
polymorphens
Prior art date
Application number
AT04806734T
Other languages
English (en)
Inventor
Venkatasubramanian Tarur
Dhananjay Sathe
Avinash Naidu
Umesh Aher
Original Assignee
Usv Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Ltd filed Critical Usv Ltd
Application granted granted Critical
Publication of ATE448203T1 publication Critical patent/ATE448203T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04806734T 2004-06-29 2004-07-22 1-benzyl-4-ä(5,6-dimethoxy-1-indanon)-2- ylümethylpiperidinoxalat und dessen polymorphen ATE448203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/879,816 US7439365B2 (en) 2003-11-17 2004-06-29 Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
PCT/IN2004/000220 WO2006001031A1 (en) 2004-06-29 2004-07-22 1-benzyl-4- ` (5,6-dimethoxy-1-indanone)-2-yl! methyl piperidine oxalate (donepezil oxalate) and its polymorphs

Publications (1)

Publication Number Publication Date
ATE448203T1 true ATE448203T1 (de) 2009-11-15

Family

ID=34959819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806734T ATE448203T1 (de) 2004-06-29 2004-07-22 1-benzyl-4-ä(5,6-dimethoxy-1-indanon)-2- ylümethylpiperidinoxalat und dessen polymorphen

Country Status (15)

Country Link
US (1) US7439365B2 (de)
EP (1) EP1761492B1 (de)
JP (1) JP2007536209A (de)
KR (1) KR20060090245A (de)
CN (1) CN1874998A (de)
AT (1) ATE448203T1 (de)
AU (1) AU2004320911A1 (de)
CA (1) CA2549752C (de)
DE (1) DE602004024129D1 (de)
EA (1) EA200700150A1 (de)
ES (1) ES2336572T3 (de)
PL (1) PL1761492T3 (de)
PT (1) PT1761492E (de)
WO (1) WO2006001031A1 (de)
ZA (1) ZA200602133B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0401850A3 (en) * 2004-09-15 2008-03-28 Egis Gyogyszergyar Nyilvanosan Donepezil salts for producing pharmaceutical composition
DE102004046497A1 (de) * 2004-09-23 2006-04-06 Helm Ag Donepezil-Salze
US7592459B2 (en) * 2004-09-29 2009-09-22 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
EP1830886B1 (de) * 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Verfahren zur stabilisierung eines arzneimittels gegen demenz
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
US20100113793A1 (en) * 2006-03-20 2010-05-06 Ind-Swift Laboratories Limited Process for the Preparation of Highly Pure Donepezil
ES2415166T3 (es) 2007-09-28 2013-07-24 Tianjin Hemay Bio-Tech Co., Ltd. Polímorfos de sales de Donepezilo, métodos de preparación y usos de los mismos
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
US20140243278A1 (en) * 2011-07-05 2014-08-28 Sunil Sadanand Nadkarni Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof
CN108976163B (zh) * 2017-06-05 2023-08-11 上海奥博生物医药股份有限公司 一种多奈哌齐双羟萘酸盐新的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
DE69822218T2 (de) * 1997-12-05 2005-02-03 Eisai Co., Ltd. Donepezil polykristalle und verfharen zu ihrer herstellung

Also Published As

Publication number Publication date
DE602004024129D1 (de) 2009-12-24
AU2004320911A1 (en) 2006-04-27
KR20060090245A (ko) 2006-08-10
EA200700150A1 (ru) 2007-08-31
JP2007536209A (ja) 2007-12-13
EP1761492B1 (de) 2009-11-11
US7439365B2 (en) 2008-10-21
US20050107613A1 (en) 2005-05-19
PL1761492T3 (pl) 2010-05-31
CA2549752C (en) 2010-04-13
EP1761492A1 (de) 2007-03-14
CA2549752A1 (en) 2006-01-05
PT1761492E (pt) 2010-02-18
CN1874998A (zh) 2006-12-06
ES2336572T3 (es) 2010-04-14
WO2006001031A1 (en) 2006-01-05
ZA200602133B (en) 2007-06-27
AU2004320911A8 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
ATE448203T1 (de) 1-benzyl-4-ä(5,6-dimethoxy-1-indanon)-2- ylümethylpiperidinoxalat und dessen polymorphen
EA200700673A1 (ru) Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид
DE69739622D1 (de) Polymorphe von Donepezil-Hydrochlorid und Verfahren zur Herstellung
ATE382353T1 (de) Substiuierte piperidine als melanocortinrezeptor- modulatoren
IL189986A0 (en) Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof
IS7085A (is) Setin anilinísk píperidín sem MCH kjörvís mótlyf
ATE328879T1 (de) Piperidin derivate als ccr5 rezeptor antagonisten zur behandlung von hiv
EP2422766A3 (de) Verfahren zur Herstellung von Trockenpulverzusammensetzungen von Glykopyrrolat
IL162484A (en) Pyrrolidine and piperidine derivatives as nk1 antagonists
IL166795A (en) N - aryl piperidine substituted biphenylcarboxamides, pharmaceutical composiitons comprising them and method for their preparation
ATE462701T1 (de) Verfahren zur herstellung von 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidin 1-carboxylsäure- derivaten und damit zusammenhängenden verbindungen
MX2011005090A (es) Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)feni l] piperidina.
DE60203481D1 (de) Piperidinderivate als neurokinin 1 antagonisten
TW200604173A (en) Novel compounds
IS4752A (is) Aðferðir og milliefni til að framleiða 1-bensýl-4-((5,6-dýmetoxý-1-indanón)-2-ýl)metýlpíperidín
NO984861L (no) Piperidiner og pyrrolidiner
EP1935884A3 (de) Neue kristalline Formen einer Donepezilbase
EA200801339A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из неё таблетка и способ её получения
ATE356115T1 (de) Verfahren zur herstellung von 1-benzyl-4- (5,6- dimethoxy-1-indanon)-2-ylö methylpiperidin hydrochlorid (donepezil hcl)
IL188916A0 (en) Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine
EP1616861A3 (de) Verfahren zur Herstellung von Keto-Verbindungen
EA200100098A1 (ru) Соли пароксетина
HUP0201673A3 (en) Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid
WO2005076749A3 (en) A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine
BR0315092A (pt) Derivados de piperidina como inibidores de ccr5

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties